🔗 Share this article

The prestigious award in Physiology or Medicine has been granted for transformative findings that clarify how the immune system targets dangerous pathogens while protecting the healthy tissues.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

The research identified unique "security guards" within the immune system that eliminate rogue immune cells capable of harming the body.

These findings are now enabling innovative therapies for autoimmune diseases and cancer.

These laureates will share a prize fund valued at 11 million SEK.

Decisive Findings

"The work has been decisive for comprehending how the immune system functions and why we do not all suffer from serious self-attack conditions," stated the head of the award panel.

This team's research explain a fundamental mystery: In what way does the immune system defend us from numerous infections while keeping our healthy cells unharmed?

The immune system employs white blood cells that scan for signs of infection, including viruses and bacteria it has never encountered.

Such defenders employ detectors—known as receptors—that are produced randomly in a vast number of variations.

This provides the defense network the ability to combat a wide array of invaders, but the randomness of the mechanism inevitably produces white blood cells that can target the host.

Security Guards of the Body

Researchers previously knew that some of these problematic defense cells were eliminated in the thymus—where immune cells develop.

This year's Nobel Prize honors the identification of T-reg cells—known as the immune system's "security guards"—which travel through the system to neutralize other immune cells that assault the body's own tissues.

We know that this process fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "The discoveries have established a novel area of research and spurred the development of new therapies, for example for cancer and autoimmune diseases."

Regarding malignancies, T-regs prevent the system from attacking the tumor, so studies are aimed at lowering their quantity.

In self-attack disorders, experiments are testing boosting regulatory T-cells so the organism is not under attack. A comparable approach could also be useful in minimizing the chances of transplanted organ rejection.

Pioneering Experiments

Prof Shimon Sakaguchi, from Osaka University, conducted experiments on mice that had their immune gland removed, causing autoimmune disease.

He demonstrated that injecting defense cells from other animals could prevent the illness—implying there was a system for blocking defenders from attacking the host.

Dr. Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic immune disorder in rodents and people that led to the discovery of a genetic factor critical for the way T-regs function.

"The groundbreaking research has uncovered how the immune system is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," said a leading biological science specialist.

"This work is a remarkable illustration of how basic physiological research can have far-reaching implications for public health."